BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) founder and CEO Tiffany Thorn speaks to Proactive about the "completely new approach" the company has been pioneering within the realm of oncology.
She reveals more details about the "fundamental step" that BiVictrix has taken recently and lays out her vision for the long-term future of the company.